Pain in Cancer Survivors
1 other identifier
observational
200
1 country
1
Brief Summary
The purpose of this study is to find out about the pain and quality of life of individuals who are adult cancer survivors. By quality of life, we mean how you are feeling about different aspects of your life, including your physical health, your emotional health, and your ability to carry out daily activities. We are interested in people's opinions about their quality of life, as well as the factors that affect their quality of life. In addition, learning about pain will help us to develop new services for adult cancer survivors.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started May 2007
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2007
CompletedFirst Submitted
Initial submission to the registry
December 21, 2007
CompletedFirst Posted
Study publicly available on registry
December 28, 2007
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2012
CompletedJanuary 26, 2012
January 1, 2012
4.7 years
December 21, 2007
January 25, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Descriptive statistics will be generated to describe the prevalence of pain and its psychosocial correlates.
1 to 10 years post-treatment completion
Study Arms (1)
1
First 50 breast cancer survivors and then after demonstrating feasibility of the study design in the first 50 participants, recruitment will be opened to the other services Colorectal, Genitourinary, Head and Neck, and Thoracic. Participants will be recruited in allotments of 50 patients from each service.
Interventions
We estimate that the completion time for the telephone interview or self-report survey will be 45-60 minutes.
Eligibility Criteria
Adult cancer survivors that were treated for cancer at Memorial Sloan-Kettering Cancer Center (MSKCC) and it has been at least a year since you completed treatment.
You may qualify if:
- Cancer treatment at MSKCC
- Are from 1 to 10 years post-treatment completion at the time of study recruitment
- No evidence of disease (NED) at the time of assessment;
- Over 18 years of age
- Can be reached by telephone
- Able to provide informed consent
- Able to speak and read English
- Cancer survivors who received adjuvant therapies outside MSKCC will be asked to self-report the type and duration of cancer treatments received.
You may not qualify if:
- Undergoing active cancer treatment (ongoing tamoxifen use, hormone replacement therapy or use of biologics are permitted)
- Evidence of encephalopathy, psychotic illness or cognitive impairment severe enough to preclude giving informed consent to the study staff, or completing the survey instruments of the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Memorial Sloan Kettering Cancer Centerlead
- Beth Israel Medical Centercollaborator
- Vanderbilt Universitycollaborator
Study Sites (1)
Memorial Sloan-Kettering Cancer Center
New York, New York, 10065, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Steven Passik, PhD
Memorial Sloan Kettering Cancer Center
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 21, 2007
First Posted
December 28, 2007
Study Start
May 1, 2007
Primary Completion
January 1, 2012
Study Completion
January 1, 2012
Last Updated
January 26, 2012
Record last verified: 2012-01